DFDA

Ribavirin

Treatment for Acute Hepatitis E

Typical Dosage: 600-1200 mg daily

Effectiveness
85%
Safety Score
55%
Clinical Trials
70
Participants
3.5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
600-1200 mg daily
Time to Effect
2-4 weeks
Treatment Duration
3-6 months
Evidence Quality
MODERATE
Confidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$6,000
Monitoring:$900
Side Effect Mgmt:$500
Total Annual:$7,400
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$45,000/QALY
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$8,705.88
Cost per Remission
$9,250
Ribavirin Outcomes

for Acute Hepatitis E

Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+85%
Remission Rate
+80%
Common Side Effects
Hemolytic anemia
+25%
Fatigue
+20%
Nausea
+15%
Teratogenicity
+1%

Sources:

nih.gov
nih.gov
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov